Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4268 (miR-4268) is a member of the microRNA family, consisting of a short (20-24 nucleotide) non-coding RNA molecule that plays a crucial role in the post-transcriptional regulation of gene expression in multicellular organisms[4]. miR-4268 is processed from a primary transcript by Drosha and Dicer enzymes, resulting in mature miRNA that is incorporated into the RNA-induced silencing complex (RISC), which binds target messenger RNAs for translational inhibition or destabilization[4]. According to experimental evidence, miR-4268 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, arresting the cell cycle in the G1/S phase, and inducing apoptosis through regulation of signaling pathways (AKT/JNK and p38 MAPK), primarily by targeting the Rab6B gene[1]. There are currently no known drugs that directly target miR-4268, nor are there established safety concerns or biomarker uses described in the literature at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4268 (miR-4268).